Israeli Researchers Identify New Protein Activity Linked To Alzheimer’s

A new study by University of Haifa scientists has identified a new form of activity by brain proteins associated with memory impairments in Alzheimer’s disease, and has also found that “repairing” this activity leads to an improvement in memory.

“In the study we found that the nerve cells in the mouse models of Alzheimer’s face a type of metabolic stress,” said Yifat Segev, who undertook the study with colleagues from the Sagol Department of Neurobiology at the University of Haifa. “When a cell faces such metabolic stress, it is logical that it will reduce its activity level in order to survive. The problem is that this stress is chronic and leads to impairment of cognitive functioning.”

Researchers, including doctors from Norway who also took part in the study, hope that a new startup they have founded on the basis of the findings will enable the development of a drug that will delay the onset of cognitive symptoms.

A previous study at the same laboratory, directed by Prof. Kobi Rosenblum, found a connection between a genetic condition known to be a risk factor for sporadic Alzheimer’s and premature aging as manifested in ongoing metabolic stress. Segev has now reached an even deeper understanding of the abnormality of the process and, in particular, finds that “repairing” the process improves the ability to create new memories.

“In previous studies we showed that it is possible to improve long-term memory by regulating the course of the PKR protein and the eIF2 in models in young and healthy animals,” said Rosenblum. “Then we found a connection between eIF2 and cognitive impairment in the context of Alzheimer’s. Now, we have not only deepened our understanding of these processes, but we have also managed to show that it is possible to cause a cognitive improvement in an Alzheimer’s model. I hope that the new start-up we established on the basis of these findings will enable a drug to be found that can delay the onset of cognitive symptoms in dementia patients and in people with various cognitive impairments.”

The study was recently published in the Journal of Neuroscience.

(via Israel21c)

[Photo: AlzheimerUniversal / YouTube ]